Alzinova AB (publ) (STO:ALZ)
Sweden · Delayed Price · Currency is SEK 0.4525
+0.0035 (0.78%)
Oct 14, 2026, 5:29 PM CET
Alzinova AB Market Cap
Alzinova AB has a market cap or net worth of 139.14 million as of October 14, 2026. It is the 39,671st most valuable company in the world and the 561st biggest in Sweden. Its market cap has decreased by 25.49% in one year.
Market Cap
139.14M
Enterprise Value
126.63M
Revenue
149.00K
Global Rank
Country Rank
#561 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2015, Alzinova AB's market cap has increased from 57.35M to 139.14M, an increase of 142.61%. That is a compound annual growth rate of 8.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 139.14M | 60.88% |
| Dec 30, 2025 | 86.48M | -71.97% |
| Dec 30, 2024 | 308.51M | 128.27% |
| Dec 29, 2023 | 135.15M | 50.50% |
| Dec 30, 2022 | 89.80M | -11.61% |
| Dec 30, 2021 | 101.60M | -13.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 251.91M |
| Elicera Therapeutics AB | 193.54M |
| Simris Group AB (PUBL) | 165.35M |
| Diamyd Medical AB | 157.15M |
| Xintela AB | 151.15M |
| Abera Bioscience AB | 140.62M |
| Initiator Pharma | 136.56M |
| NextCell Pharma AB | 121.72M |